Active Biotech focuses on developing pharmaceuticals for medical fields in which the immune system plays a central role.
Our pharmaceutical development is based on our specialist know-how in the field of immunology. We possess a unique infrastructure that includes highly experienced researchers who combine cutting edge expertise with efficient project work focusing on clearly defined targets. Our portfolio includes innovative substances that modulate the human immune system. We have made most progress in developing products designed to treat multiple sclerosis, as well as lung, renal and pancreatic cancer.
| Contact Details: |
| Box 724 |
| Lund |
| |
| SE-22007 |
| Sweden |
| Tel: | +46-46-191040 |
| Fax: | +46-46-191041 |
| Email: | karl.branzen@activebiotech.com |
| WWW: | www.activebiotech.com/
|
| |
Recent Publications by Active Biotech Research AB: |  |
Increased degradation rate of nitrososureas in media containing carbonate.
The stability of two nitrosoureas, tauromustine and lomustine, has been... | 8th October, 2009
| Department of Preclinical Development, Active Biotech Research AB, P.O.
| In Vitro Cell Dev Biol Anim. 2009 Jan-Feb;45(1-2):32-4. Epub 2008 Oct 15.
DOI Direct Link |
Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
In this study we explored the possibility of combining immunotherapy... | 5th May, 2009
| Active Biotech Research AB, Lund, Sweden.
| Int Immunopharmacol. 2009 Aug;9(9):1063-70. Epub 2009 May 3.
DOI Direct Link |
Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
In this study we explored the possibility of improving the anti-tumor... | 9th April, 2008
| Active Biotech Research AB, P.O. Box 724, SE-220 07 Lund, Sweden.
| Int Immunopharmacol. 2008 Mar;8(3):442-52. Epub 2007 Dec 7.
DOI Direct Link |
Discovery of selective small-molecule CD80 inhibitors.
Protein-protein interactions are widely found in biological systems... | 19th August, 2007
| Active Biotech Research AB, Lund, Sweden.
| J Biomol Screen. 2007 Jun;12(4):464-72. Epub 2007 Apr 13.
DOI Direct Link |
Determination of the immunomodulator laquinimod in human plasma by liquid chromatography/tandem mass spectrometry; development, validation and application of two methods in clinical pharmacokinetic profiling.
Laquinimod (ABR-215062) is a synthetic compound currently undergoing... | 20th January, 2007
| Research and Development Laboratories, Active Biotech Research AB, Box
| Rapid Commun Mass Spectrom. 2006;20(22):3313-8.
DOI Direct Link |
→View more Active Biotech Research AB research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 604 times since April 2007, the link to the organisation's website has been followed 115 times
Recent Search Terms used to find this page: ACTIVE BIOTECH RESearch | Active Biotech Research AB | Active biotech research | .
Search for more companies in Lund
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Active Biotech Research AB
